COMMUNIQUÉS West-GlobeNewswire

-
De-listing and cancellation of trading of Shire Shares
09/01/2019 -
Basilea reports positive interim results from registrational phase 2 study with oncology drug candidate derazantinib in intrahepatic cholangiocarcinoma (iCCA)
09/01/2019 -
RadioMedix and Curium Announce FDA Fast Track Designation For 64Cu-Dotatate.
09/01/2019 -
Mesa's Board Announces Death of Board Member H. Stuart Campbell
09/01/2019 -
Akorn Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/01/2019 -
Management Cease Trade Order Update
09/01/2019 -
MediciNova Announces Initiation of Enrollment in a Clinical Trial of MN-166 (ibudilast) in Glioblastoma
09/01/2019 -
LeMaitre Vascular to Present at the Needham Growth Conference on Wednesday, January 16, 2019
08/01/2019 -
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
08/01/2019 -
IRIDEX Announces Preliminary Operational and Financial Results for 2018 Fourth Quarter and Full Year
08/01/2019 -
Sands Capital reports 5.7% holding in Galapagos
08/01/2019 -
Xyngular Introduces Accelerate with Thermolit Blend
08/01/2019 -
How to Prevent Common Skin Infections at the Gym; American Academy of Dermatology
08/01/2019 -
Quell Named CES 2019 Innovation Awards Honoree
08/01/2019 -
Abeona Therapeutics Strengthens Financial Leadership with New Executive Appointments
08/01/2019 -
B. Braun’s OnGuard® CSTD Qualifies as an Effective Barrier for Vapor Release Based on the NIOSH Draft Universal Protocol
08/01/2019 -
Hemispherx Biopharma Announces IRB Approval of Clinical Study in Metastatic Triple Negative Breast Cancer in Collaboration with Roswell Park Comprehensive Cancer Center
08/01/2019 -
Phoenix Life Sciences International Announces 2019 International Expansion Strategy
08/01/2019 -
Genmab Achieves USD 75 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen
08/01/2019
Pages